Cargando…
Tocilizumab in severe COVID-19: A promise fulfilled
Autor principal: | Levi, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606258/ https://www.ncbi.nlm.nih.gov/pubmed/34836747 http://dx.doi.org/10.1016/j.ejim.2021.11.015 |
Ejemplares similares
-
Tocilizumab for severe COVID-19: A promising intervention affecting inflammation and coagulation
por: Levi, Marcel
Publicado: (2020) -
Tocilizumab is recommended for the treatment of severe COVID-19
por: Zhou, Yonggang, et al.
Publicado: (2020) -
Fulfilling the promise of digital health interventions (DHI) to promote women’s sexual, reproductive and mental health in the aftermath of COVID-19
por: Chattu, Vijay Kumar, et al.
Publicado: (2021) -
Why tocilizumab could be an effective treatment for severe COVID-19?
por: Fu, Binqing, et al.
Publicado: (2020) -
A Promise Generously Fulfilled
Publicado: (1885)